Nicaise Claude 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 8, 2023
Insider Transaction Report
Form 4
Nicaise Claude
Director
Transactions
- Award
Stock Option (right to buy)
2023-03-06+3,257→ 3,257 totalExercise: $155.99From: 2024-03-06Exp: 2033-03-06→ Common Stock (3,257 underlying) - Award
Common Stock
2023-03-06+1,523→ 16,328 total
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024.